Tech Enhanced Investing

Glenmark Pharmaceuticals shares traded marginally higher on the BSE, rising 0.08% to RS 2,183.30 compared to the previous close of RS 2,181.45. The stock opened at RS 2,185.30 and moved between an intraday high of RS 2,215.00 and a low of RS 2,181.00. Around 6,145 shares changed hands during the session.

The company’s stock, carrying a face value of RS 1, has recorded a 52-week high of RS 2,471.05 and a 52-week low of RS 1,515.55. Over the past week, the share price has fluctuated between RS 2,144.40 and RS 2,439.70. Glenmark currently commands a market capitalization of approximately RS 62,329.69 crore.

Shareholding data shows promoters own 46.65% of the company, while institutional investors hold 39.67% and non-institutional investors account for 13.68%.

The positive sentiment follows the launch of Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), by Glenmark’s wholly owned US subsidiary, Glenmark Pharmaceuticals Inc. The newly introduced product is a generic version that is both bioequivalent and therapeutically equivalent to UCB Inc.’s Vimpat Injection.

According to industry sales estimates, the reference drug Vimpat Injection generated annual sales of nearly $15.2 million in the US market during the 12 months ended April 2026, highlighting the commercial opportunity for Glenmark’s generic offering.

Glenmark Pharmaceuticals is a research-driven global pharmaceutical company with a strong presence across generic medicines, specialty products, and over-the-counter healthcare segments, operating in multiple international markets.

Mumbai: Shares of Alembic Pharmaceuticals moved higher in early trade after the company announced that it has secured final approval from the US Food and Drug Administration (USFDA) for its generic Haloperidol Tablets in multiple strengths.

The stock was trading at RS 738.90, registering a gain of RS 3.20, or 0.43%, compared to its previous close of RS 735.70 on the BSE. During the session, the stock opened at RS 736.10 and fluctuated between an intraday high of RS 743.00 and a low of RS 728.20. Around 19,676 shares had changed hands on the counter.

Alembic Pharmaceuticals received final USFDA clearance for its Abbreviated New Drug Application (ANDA) for Haloperidol Tablets USP in strengths of 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg. The approved product is the generic equivalent of Haldol Tablets, originally marketed by Ortho McNeil Pharmaceutical.

Haloperidol is prescribed for the treatment of symptoms associated with psychotic disorders and is also used to manage tics and vocal manifestations linked to Tourette’s Disorder in both children and adults.

According to IQVIA data, the approved product segment recorded an estimated market opportunity of approximately $27 million in the 12-month period ending March 2026. With this latest approval, Alembic’s cumulative USFDA ANDA portfolio has expanded to 240 approvals, comprising 221 final approvals and 19 tentative approvals.

On the market front, the company’s market capitalization stood at about RS 14,524.05 crore. The stock has touched a 52-week high of RS 1,107.80 and a 52-week low of RS 635.30. Promoters hold 69.74% of the company, while institutional and non-institutional investors own 20.43% and 9.83%, respectively.

Alembic Pharmaceuticals operates across India formulations, international generics, and active pharmaceutical ingredients (APIs), supported by its vertically integrated manufacturing capabilities.

Innovision witnessed strong buying interest during trading on Thursday, with its share price rising 8.83% to RS 309.25 on the BSE, compared to the previous closing level of RS 284.15. The stock gained RS 25.10 during the session.

The counter opened at RS 288.20 and moved within a trading range of RS 288.20 to RS 324.35. A total of 58,660 shares changed hands during the trading session.

The stock, which carries a face value of RS 10 and is listed under the BSE 'B' group category, touched its 52-week peak of RS 468.60 on March 23, 2026, while its 52-week low of RS 283.75 was recorded on June 4, 2026. Over the past week, the share has traded between RS 283.75 and RS 332.95.

Innovision currently commands a market capitalization of approximately RS 735.95 crore. Promoters hold a 74.17% stake in the company, while institutional investors and non-institutional investors own 0.45% and 25.38%, respectively.

The positive momentum in the stock follows the company's receipt of a Letter of Award (LoA) from the National Highways Authority of India (NHAI) for a project valued at around RS 26.35 crore. The contract involves operating the Mundiyar Fee Plaza on the Baran-Shivpuri section of New NH-27 in Madhya Pradesh, along with maintenance of nearby toilet facilities and replenishment of consumable items.

The project is scheduled to commence on July 11, 2026, and will remain in force for a period of one year.

Innovision operates across multiple service segments, including manpower solutions, toll plaza operations and management, and skill development training programs for clients throughout India.

Bharat Gears shares traded higher on the BSE, gaining 0.79% to RS 114.30, compared to the previous closing price of RS 113.40. The stock opened at RS 116.20 and touched an intraday high of RS 116.20, while the day's low stood at RS 114.30. Around 120 shares changed hands during the trading session.

The company’s stock, which carries a face value of RS 10, had reached a 52-week high of RS 154.35 on September 29, 2025, and a 52-week low of RS 83.65 on March 30, 2026. Over the past week, the stock has fluctuated between RS 105.30 and RS 121.70. Bharat Gears currently commands a market capitalization of approximately RS 177.50 crore.

Shareholding data indicates that promoters hold a 55.33% stake in the company, while institutional investors own 1.44% and non-institutional investors account for the remaining 43.23%.

In a significant development, Bharat Gears has invested RS 1.27 crore in Hexa Energy HR5 by acquiring 13,134 equity shares with a face value of RS 101 each. The shares were subscribed at an issue price of RS 970 per share, giving Bharat Gears a 29.55% stake in the company’s paid-up equity capital.

The investment has been undertaken to meet regulatory requirements under prevailing electricity laws and to facilitate the procurement of solar power for the company’s manufacturing facilities located in Faridabad and Mumbra.

Bharat Gears is recognized as one of India’s leading gear manufacturers and a prominent player in global gear technology. The company produces a broad portfolio of automotive components, including ring gears, pinions, transmission gears, shafts, differential gears, and gearboxes, catering primarily to the automotive sector.

DMR Engineering witnessed strong buying interest in Tuesday’s trading session, with its stock rising 8.89% to RS 34.30 on the BSE, gaining RS 2.80 from the previous close of RS 31.50.

The stock opened at RS 32.00 and touched an intraday high of RS 34.30, which also remained its day’s low, while around 25,350 shares changed hands during the session.

The company’s share, having a face value of RS 10, recorded a 52-week peak of RS 69.65 on August 29, 2025, and recently hit a 52-week low of RS 28.18 on June 4, 2026. Over the past week, the stock has traded within a range of RS 28.18 to RS 45.99. DMR Engineering currently commands a market capitalization of approximately RS 35.34 crore.

Shareholding data shows promoters own 69.32% of the company, while the remaining 30.68% is held by non-institutional investors.

In a significant business development, DMR Engineering has been awarded a contract by Dorjilung Hydro Power in Bhutan. The assignment involves providing short-term owner’s engineer services for the 1,125 MW Dorjilung Hydropower Project. The nine-month contract is valued at RS 2.58 crore, excluding applicable taxes.

Formerly known as DMR Hydroengineering & Infrastructures, DMR Engineering specializes in engineering and design solutions for infrastructure projects, offering end-to-end services from project conceptualization to commissioning.

Shares of Agarwal Industrial Corporation surged sharply on Tuesday, hitting the upper circuit limit of 20% at RS 503.55 on the BSE. The stock gained RS 83.90 from its previous closing price of RS 419.65, reflecting strong investor enthusiasm following a major contract win.

The stock opened at RS 442.20 and remained on an upward trajectory throughout the session, touching an intraday high of RS 503.55, which also stood as its day’s low after being locked in the upper circuit. Trading activity remained healthy, with over 1.16 lakh shares changing hands.

Over the past year, the company's stock has recorded a 52-week high of RS 1,023.40 on June 6, 2025, and a 52-week low of RS 360.45 on March 30, 2026. During the last week, the share price traded between RS 397.20 and RS 503.55. The company currently commands a market capitalization of approximately RS 753.20 crore.

Promoters continue to hold a majority stake of 57.20% in the company, while institutional investors own 4.70% and non-institutional investors account for 38.10% of the shareholding.

Investor sentiment received a boost after the company announced that it had secured a significant order from Hindustan Petroleum Corporation (HPCL) valued at around RS 477.50 crore. The contract involves supplying nearly 1.30 lakh metric tonnes of Bulk Bitumen in VG-30 and VG-40 grades to HPCL facilities located in Mumbai and Mangalore. Deliveries are scheduled to be executed between May 25, 2026, and May 24, 2027.

The order strengthens Agarwal Industrial Corporation’s position in the bitumen supply segment and reinforces its long-standing business association with HPCL.

Agarwal Industrial Corporation operates across multiple business segments, including the manufacturing and trading of bitumen and other petrochemical products, logistics services for bitumen and LPG, and renewable energy generation through wind power projects.

JBM Auto shares witnessed strong buying interest on the BSE, rising 6.35% to RS 710.50, an increase of RS 42.40 from the previous close of RS 668.10. The stock opened at RS 691.45 and moved between an intraday high of RS 718.80 and a low of RS 689.50. Trading activity remained robust, with more than 7.15 lakh shares changing hands during the session.

The company's stock, which carries a face value of RS 1, has recorded a 52-week high of RS 790.00 and a 52-week low of RS 477.00. Over the past week, it traded within a range of RS 607.90 to RS 718.80. JBM Auto currently commands a market capitalization of approximately RS 16,814.74 crore.

Shareholding data shows promoters holding a dominant 67.53% stake in the company, while institutional investors own 2.08% and non-institutional investors account for 30.39%.

On the business front, JBM Auto has secured the top position in India's electric bus industry, capturing a 49% market share in May 2026, according to data available on the Vahan portal. The company registered 157 electric buses during the month, the highest among industry participants.

The latest achievement follows the company's strong performance throughout FY26, during which it maintained leadership in electric bus registrations. Its continued dominance highlights increasing demand for its electric mobility offerings and efficient execution capabilities. The inclusion of Telangana's vehicle registration data into the Vahan portal from May 2026 has also provided a broader picture of nationwide market performance.

JBM Auto's growth has been supported by its advanced manufacturing infrastructure, which enables the production of lightweight yet high-strength electric bus platforms designed for sustainable public transportation. The company continues to integrate global technologies into its products to deliver scalable and dependable electric mobility solutions.

JBM Auto serves as the flagship entity of the JBM Group and operates across various automotive segments, including the manufacturing of sheet metal components, tools, dies, moulds, and buses, along with spare parts, accessories, and bus maintenance services.

Shares of Hero MotoCorp traded higher on the BSE, gaining over 1% during the session. The stock was quoted at RS 4,891.55, up RS 49.05 from its previous close of RS 4,842.50. During the day, the counter opened at RS 4,859.90 and moved between an intraday high of RS 4,915.00 and a low of RS 4,857.85.

The company’s stock, which carries a face value of RS 2, has recorded a 52-week high of RS 6,390.00 and a 52-week low of RS 4,160.00. Over the past week, the share price has fluctuated between RS 5,458.00 and RS 4,746.20. Hero MotoCorp currently commands a market capitalization of approximately RS 96,895 crore.

Shareholding data shows promoters own 34.73% of the company, while institutional investors hold 55.93% and non-institutional investors account for 9.34%.

In a significant move towards sustainable mobility, Hero MotoCorp has introduced its first Flex Fuel motorcycles—the popular Splendor+ and HF Deluxe. The launch marks the arrival of India’s first Flex Fuel motorcycles in the 100cc category, supporting the country’s efforts to promote cleaner transportation alternatives.

Designed for everyday riders, the new motorcycles can operate on ethanol-blended fuels ranging from E20 to E85. The company believes the models will provide a practical and affordable commuting solution while helping reduce carbon emissions and supporting India's goal of lowering economic carbon intensity by 45% by 2030.

The Flex Fuel range will initially be launched in Delhi and selected regions of Maharashtra in July 2026, with a phased expansion across the country planned thereafter. The HF Deluxe Flex Fuel has been priced at RS 72,792 (ex-showroom Delhi), while the Splendor+ Flex Fuel will be available at RS 82,710 (ex-showroom Delhi).

Hero MotoCorp remains the world’s largest producer of motorcycles and scooters, and the latest launch further strengthens its focus on innovation and environmentally friendly mobility solutions.

Tech Mahindra’s stock witnessed positive momentum in trading on Thursday, rising 0.88% to RS 1,486.00 compared to its previous close of RS 1,473.05 on the BSE. The stock opened at RS 1,462.00 and moved within an intraday range of RS 1,451.95 to RS 1,491.05. Trading activity remained moderate, with over 13,000 shares changing hands during the session.

The company’s stock, carrying a face value of RS 5 per share, has recorded a 52-week high of RS 1,850.00 and a 52-week low of RS 1,304.25. Over the past week, the share price has fluctuated between RS 1,327.65 and RS 1,589.00. Tech Mahindra currently commands a market capitalization of approximately RS 1.45 lakh crore.

Shareholding data shows promoters owning 34.97% of the company, while institutional investors hold 56.08% and non-institutional investors account for 8.95%.

In a significant strategic move, Tech Mahindra has introduced its new Agentic Development & Modernization Services (ADMS) portfolio. The offering is designed to help enterprises transform the way applications are developed, managed, and upgraded by integrating advanced agentic artificial intelligence throughout the software lifecycle.

The company said the initiative represents a shift in the traditional meaning of ADMS—from Application Development and Maintenance Services to Agentic Development and Modernization Services. Leveraging its extensive experience in software engineering and managed services, Tech Mahindra aims to combine AI-driven automation with deep engineering capabilities to modernize legacy systems and create future-ready digital platforms.

The newly launched services utilize agentic AI, contextual intelligence, and automated orchestration to enable applications to continuously assess, adapt, and respond to changing business requirements. This approach is expected to reduce manual effort, improve operational efficiency, enhance software quality, and accelerate development cycles.

According to the company, the portfolio will help organizations achieve greater agility, predictable operations, scalable application environments, and stronger business outcomes through increased automation and intelligent decision-making.

The launch supports Tech Mahindra’s broader vision of enabling autonomous enterprises by helping businesses transition from conventional application ecosystems to AI-native, intelligent digital environments that promote continuous innovation and growth.

Tech Mahindra is a leading provider of technology consulting and digital transformation services, serving global enterprises across multiple industries with innovative and scalable solutions.

Bliss GVS Pharma witnessed strong buying interest in Thursday’s trading session, with its stock climbing 1.76% to RS 442.40 on the BSE, gaining RS 7.65 from the previous close of RS 434.75.

The stock opened at RS 436.90 and moved between an intraday high of RS 447.35 and a low of RS 429.25. Around 1.74 lakh shares had changed hands on the counter during the session.

The company’s RS 1 face-value share reached a fresh 52-week high of RS 447.35 on June 3, 2026, while its 52-week low stood at RS 118.35 recorded on November 10, 2025. Over the past week, the stock has traded within a range of RS 265.30 to RS 447.35.

Bliss GVS Pharma currently commands a market capitalization of approximately RS 4,622.98 crore. Promoters hold a 35.36% stake in the company, while institutional investors own 15.49% and non-institutional investors account for 49.15%.

The positive momentum in the stock comes after the company received an Inspection Closure Report from the World Health Organization (WHO) for its manufacturing facility in Palghar (East), Maharashtra. The report confirms that the plant complies with WHO-issued Good Manufacturing Practices (GMP) standards, reinforcing the company’s commitment to global quality and regulatory requirements.

Bliss GVS Pharma is engaged in the development, manufacturing, and marketing of pharmaceutical formulations and has established a strong presence in international markets by offering quality healthcare products at affordable prices.